Journal article icon

Journal article

Conclusion of diagnostic odysseys due to inversions disrupting <i>GLI3</i> and <i>FBN1</i>

Abstract:
Many genetic testing methodologies are biased towards picking up structural variants (SVs) that alter copy number. Copy-neutral rearrangements such as inversions are therefore likely to suffer from underascertainment. In this study, manual review prompted by a virtual multidisciplinary team meeting and subsequent bioinformatic prioritisation of data from the 100K Genomes Project was performed across 43 genes linked to well-characterised skeletal disorders. Ten individuals from three independent families were found to harbour diagnostic inversions. In two families, inverted segments of 1.2/14.8 Mb unequivocally disrupted GLI3 and segregated with skeletal features consistent with Greig cephalopolysyndactyly syndrome. For one family, phenotypic blending was due to the opposing breakpoint lying ~45 kb from HOXA13. In the third family, long suspected to have Marfan syndrome, a 2.0 Mb inversion disrupting FBN1 was identified. These findings resolved lengthy diagnostic odysseys of 9–20 years and highlight the importance of direct interaction between clinicians and data-analysts. These exemplars of a rare mutational class inform future SV prioritisation strategies within the NHS Genomic Medicine Service and similar genome sequencing initiatives. In over 30 years since these two disease-gene associations were identified, large inversions have yet to be described and so our results extend the mutational spectra linked to these conditions
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/jmg-2022-108753
Publication website:
https://eprints.whiterose.ac.uk/194498/1/jmg-2022-108753.full.pdf

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7334-0602
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7752-9971
More by this author
Role:
Author
ORCID:
0009-0008-4699-4545


More from this funder
Funder identifier:
10.13039/100010269
Grant:
203141/Z/16/Z
More from this funder
Funder identifier:
10.13039/501100000265
Grant:
MR/W01761X/1
More from this funder
Funder identifier:
10.13039/501100000289


Publisher:
BMJ Publishing Group
Journal:
Journal of Medical Genetics More from this journal
Volume:
60
Issue:
5
Pages:
505-510
Publication date:
2022-11-21
Acceptance date:
2022-10-14
DOI:
EISSN:
1468-6244
ISSN:
0022-2593


Language:
English
Keywords:
Pubs id:
1307619
Local pid:
pubs:1307619
Source identifiers:
W4309496707
Deposit date:
2026-04-30
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP